Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome

@article{Moslein2003PreventiveSF,
  title={Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome},
  author={G. Möslein and S. Pistorius and H. Saeger and H. Schackert},
  journal={Langenbeck's Archives of Surgery},
  year={2003},
  volume={388},
  pages={9-16}
}
BackgroundA better understanding of the molecular basis of hereditary colorectal cancer syndromes such as hereditary nonpolyposis colorectal cancer syndrome (HNPCC) and familial adenomatous polyposis (FAP) has profound consequences for both the diagnosis and (prophylactic) treatment of (pre)malignant neoplastic lesions.DiscussionSequence analysis of the underlying genes for these conditions and the detection of disease-causing genetic alterations in an index patient enable predictive testing… Expand
Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer
Awareness for familial occurrence of colorectal cancer has increased but still many cases remain undetected.Diagnosis of HNPCC syndrome is of great importance since it allows early detection andExpand
The genetics of HNPCC: application to diagnosis and screening.
TLDR
This review addresses recent advances in the field of HNPCC research and their applications in the management of affected individuals and families. Expand
Lynch syndrome: implications for the surgeon.
TLDR
The diagnosis and management of Lynch syndrome will be reviewed, with emphasis on the implications for the surgeon. Expand
Surgical Options for Familial Adenomatous Polyposis
TLDR
It is now clear that the different patterns of FAP are based on different APC mutations, and it is important to offer a tailored approach, where the type of operation and the timing is based on aggressiveness of the disease and the risk of other manifestations such as desmoid tumors. Expand
Familial Adenomatous Polyposis
TLDR
Genetic testing has evolved over the past decade to play a key role in identifying at-risk individuals and assisting in recommendations made to these patients and their families with regard to screening, surgical treatment, and surveillance. Expand
Hereditary Nonpolyposis Colorectal Cancer
TLDR
The current understanding of the genetics of HNPCC, the various phenotypic expressions, genetic testing, surveillance, and current recommendations of management of this familial cancer syndrome are discussed. Expand
Surveillance in Lynch Syndrome
TLDR
Screening for colorectal adenomas and carcinomas by regular colonoscopies is the main topic of the present review and the value of screening for other extracolonic cancers remains also uncertain. Expand
Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
TLDR
Adenoma would appear to be the most important lesion preceding cancer formation in Lynch syndrome and removal of adenomas decreases the risk for colorectal cancer (CRC). Expand
Polyp Progression in Paediatric Patients with Familial Adenomatous Polyposis - A Single Centre Experience.
TLDR
The results suggest that adenoma number remains relatively stable in the majority of children under surveillance, and Tailored surveillance intervals according to phenotype are a more appropriate strategy as recommended by recently published guidelines. Expand
Wireless capsule endoscopy in adolescents with familial adenomatous polyposis
TLDR
Wireless capsule endoscopy is feasible and well-tolerated as a first screening examination in adolescent patients, but it cannot be used as alternative to the colonoscopy, but could improve compliance with colonoscope, and increase early adherence to a surveillance program. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 65 REFERENCES
Care of patients and their families with familial adenomatous polyposis.
TLDR
Management guidelines that were recently developed at Mayo Clinic Rochester to provide for uniform care and surveillance are discussed and a better understanding of the natural history of these FAP-associated phenomena will facilitate the rational selection of interventions. Expand
Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis
TLDR
IRA should be the primary treatment for polyposis in patients with mutations before codon 1250, and RPC in those with mutations after this codon. Expand
Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families
TLDR
As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. Expand
Benefits of Colonoscopic Surveillance and Prophylactic Colectomy in Patients with Hereditary Nonpolyposis Colorectal Cancer Mutations
TLDR
A decision analysis was used to assess the outcomes of various colorectal cancer preventive strategies, including colonoscopic surveillance, prophylactic colectomy, and delayed coLECTomy for patients carrying a genetic mutation associated with hereditary nonpolyposis coloreCTal cancer. Expand
Surveillance for Hereditary Nonpolyposis Colorectal Cancer: A Long-Term Study on 114 Families
TLDR
There is a substantial risk of developing colorectal cancer while on the surveillance program, however, all tumors but one of subjects who underwent a surveillance examination two years or less before detection were at a local stage. Expand
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
TLDR
Colonic screening at 3-year intervals more than halves the risk of CRC, prevents CRC deaths, and decreases overall mortality by about 65% in HNPCC families. Expand
Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli.
TLDR
This study supports the feasibility of combined molecular and clinical screening of families with FAP and may provide a guideline for routine presymptomatic molecular diagnostics in a clinical laboratory. Expand
Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers?
  • H. Lynch
  • Medicine
  • Diseases of the colon and rectum
  • 1996
TLDR
Patients who are gene carriers can be told that they have a 90 percent likelihood of developing colorectal cancer (CRC), and a considerable body of evidence that adenomas in HNPCC progress to carcinoma at a more rapid pace. Expand
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.
TLDR
Estimates of cancer risk that may contribute to the appropriate management of gene carriers within families with hereditary nonpolyposis colorectal cancer are provided. Expand
Surveillance for Hereditary Nonpolyposis Colorectal Cancer
TLDR
There is a substantial risk of developing colorectal cancer while on the surveillance program, however, all tumors but one of subjects who underwent a surveillance examination two years or less before detection were at a local stage. Expand
...
1
2
3
4
5
...